Finasteride

Excerpt

Finasteride, an FDA-approved therapeutic agent, plays a pivotal role in managing benign prostate hyperplasia and androgenic alopecia (male pattern hair loss) in men. Through its competitive inhibition of 5-alpha-reductase (types II and III isoenzymes), finasteride impedes the conversion of testosterone to dihydrotestosterone (DHT), addressing the underlying pathophysiology of these conditions. This activity discusses finasteride's diverse applications, extending beyond its primary indications to treat hyperandrogenism-associated manifestations, such as hirsutism.